Swiss Lab Falls Short on Quality Control, FDA Says in Warning Letter

Drug GMP Report
A A
Laboratoire Sintyl, based in Switzerland, was cited for multiple quality control problems in an FDA warning letter.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00